N4 Pharma Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für N4 Pharma zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 14.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?
Mar 18Here's What We Think About N4 Pharma's (LON:N4P) CEO Pay
Mar 01Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as N4 Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2023 | N/A | -1 | -1 | -1 | N/A |
3/31/2023 | N/A | -1 | -1 | -1 | N/A |
12/31/2022 | N/A | -1 | -1 | -1 | N/A |
9/30/2022 | N/A | -1 | -1 | -1 | N/A |
6/30/2022 | N/A | -1 | -1 | -1 | N/A |
3/31/2022 | N/A | -1 | -1 | -1 | N/A |
12/31/2021 | N/A | -2 | -2 | -2 | N/A |
9/30/2021 | N/A | -2 | -2 | -2 | N/A |
6/30/2021 | N/A | -2 | -2 | -2 | N/A |
3/31/2021 | N/A | -2 | -2 | -2 | N/A |
12/31/2020 | N/A | -1 | -1 | -1 | N/A |
9/30/2020 | N/A | -1 | -1 | -1 | N/A |
6/30/2020 | N/A | -1 | -1 | -1 | N/A |
3/31/2020 | N/A | -1 | -1 | -1 | N/A |
12/31/2019 | N/A | -1 | -1 | -1 | N/A |
9/30/2019 | 0 | -1 | -1 | -1 | N/A |
6/30/2019 | 0 | -1 | -1 | -1 | N/A |
3/31/2019 | 0 | -1 | -1 | -1 | N/A |
12/31/2018 | 0 | -1 | -1 | -1 | N/A |
9/30/2018 | 0 | -1 | -1 | -1 | N/A |
6/30/2018 | 0 | 0 | -1 | -1 | N/A |
3/31/2018 | 0 | 0 | -1 | -1 | N/A |
12/31/2017 | 0 | -1 | -1 | -1 | N/A |
6/30/2017 | 0 | -2 | -1 | -1 | N/A |
3/31/2017 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von N4P über der Sparquote liegt (1.5%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von N4P schneller wachsen werden als der Markt UK
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von N4P in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von N4P schneller wachsen werden als der Markt von UK.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von N4P schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von N4P in 3 Jahren voraussichtlich hoch sein wird